Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease

Gastroenterol Hepatol. 2019 May;42(5):306-307. doi: 10.1016/j.gastrohep.2018.06.006. Epub 2018 Jul 17.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / adverse effects*
  • Anti-Inflammatory Agents / adverse effects*
  • Crohn Disease / complications
  • Hepatitis, Autoimmune / etiology*
  • Humans
  • Male
  • Middle Aged

Substances

  • Anti-Inflammatory Agents
  • Adalimumab